Uncategorized
Iridex receives two patents for laser delivery system
The U.S. Patent Office has issued two patents for the TxCell scanning laser delivery system to cover key elements of Iridex’s MicroPulse technology and to improve the delivery of its subthreshold treatment for patients with glaucoma and retinal diseases, Iridex announced in a press release. The two patents, No. 9,265,656 and No. 9,278,029, will cover automatic laser delivery with multi-spot pattern scanning for retinal photocoagulation that spares tissue and enables faster treatments.